凯普生物：关于董事股份减持计划实施完毕的公告

Group 1 - The company announced a share reduction plan by its employee representative director, Mr. Xie Longxu, who holds 375,456 shares, accounting for approximately 0.0598% of the total share capital [1] - The planned reduction will involve selling up to 93,864 shares, which represents 0.0150% of the company's total share capital, through centralized bidding within three months after the announcement [1]